Accrelist to acquire 49% stake in Malaysian aesthetics company
DeeperDive is a beta AI feature. Refer to full articles for the facts.
ACCRELIST'S wholly-owned subsidiary Accrelist Medical Aesthetics is intending to acquire 49 per cent of the issued and paid-up capital of Ozhean Accrelist Aesthetics Sdn Bhd for RM490,000 (S$161,535).
Based on the latest available management accounts of Ozhean, its net asset value as at Aug 31, 2019 is approximately RM860,646.
Ozhean is a private limited company incorporated in Malaysia principally engaged in cosmetic dermatology and skin laser services. It also offers other health services such as physiotherapy, chiropractic and speech therapy.
Accrelist noted that the amount paid for Ozhean is a premium to its current net asset value, but it is of the opinion that the consideration is reasonable, due to the fact that the difference results from the startup costs incurred by Ozhean.
The company is also of the view that the value of Ozhean shares will increase once Ozhean commences its operations. No valuation was carried out in connection with the proposed share acquisition.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant